Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced it will present 18 abstracts, ...

Full abstracts will be released by ASCO on Thursday, May 22, 2025, at 5:00 PM ET. Details from the presentations will be ...

With this level of control, scientists can fine-tune how nanomedicines interact with the human body. These new designs are ...

A scientific revolution is underway as researchers push to bring atomic-level precision, once reserved for small molecule ...

Genialis, the RNA biomarker company, today announced two new studies demonstrating how predictive algorithms can drive better outcomes for patients, providers, and drug developers. In poster ...

Q1 2025 Earnings Call Transcript April 22, 2025 Danaher Corporation beats earnings expectations. Reported EPS is $1.88, ...

BioAtla, Inc. (Nasdaq: BCAB), a global clinical-stage biotechnology company focused on the development of Conditionally ...

Bruker Corporation today announced the launch of the Beacon Discoverytm Optofluidic System at the upcoming American Association for Cancer Research (AACR) Annual Meeting 2025. This new Beacon benchtop ...

Researchers at the Mount Sinai Health System will present groundbreaking science at the American Association for Cancer ...

Debiopharm ( a privately-owned, Swiss-based biopharmaceutical company aiming to establish tomorrow’s standard-of-care to cure cancer and infectious diseases and develop new antibody linker ...

Historically, the vast majority of pharmaceutical drugs have been meticulously designed down to the atomic level. The specific location of each atom ...